# US 2023/0054346 A1 · Composition comprising hyaluronic acid and a polyol and/or carboxymethyl cellulose

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0054346 A1
- Document ID: US20230054346A1
- Status: Published application
- Kind: A1
- Application number: 17/789,749
- Filed: 2021-01-21
- Published: 2023-02-23
- Earliest claimed: 2020-01-22
- Assignees: Ibsa Pharma SAS
- Applicants: Ibsa Pharma SAS
- Inventors: Yannis GUILLEMIN; Dominique VACHER; Jean-Noel GOUZE
- Web page: https://patentgrep.com/patent/US20230054346A1

## CPC

- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61K 31/728: Hyaluronic acid
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/38: Cellulose; Derivatives thereof
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to a composition comprising at least hyaluronic acid and at least one polyol and/or carboxymethyl cellulose (CMC). The invention also relates to the use of at least one polyol and/or carboxymethyl cellulose to stabilize hyaluronic acid in a composition.

## Claims

### Claim 1

A composition comprising at least hyaluronic acid and at least one polyol and/or carboxymethyl cellulose (CMC).

### Claim 2 (depends on 1)

The composition according to claim 1, characterized in that the hyaluronic acid has a molecular weight between 105 and 107 Da.

### Claim 3 (depends on 1)

The composition according to claim 1, characterized in that the polyol is a saturated or unsaturated, linear, branched or cyclic alkyl compound with at least two —OH functions on the alkyl chain, as well as polymers (polyethers) of these polyhydroxylated alkyl compounds.

### Claim 4 (depends on 3)

The composition according to claim 3, characterized in that the polyol is an alkyl compound having from 2 to 12 carbon atoms.

### Claim 5 (depends on 1)

The composition according to claim 1, characterized in that the polyol is selected from ethylene glycol [(HOCH2—CH2OH)], diethylene glycol [(HOCH2—CH2—O—CH2—CH2OH)], triethylene glycol [(HOCH2—CH2—O—CH2—CH2OCH2—CH2OH], propylene glycol [(propane-1,2-diol: HOCH2—CHOH—CH3)], trimethylene glycol [(propane-1,3-diol: HOCH2—CH2—CH2OH)]; propylene glycol, polymers and copolymers of glycerol, ethylene glycol and propylene glycol, dipropylene glycol, and hexaglycerol, hexylene glycol, pentylene glycol, butyldiglycol, 1,2,3trihydroxyhexane, butylene glycol [(butane-1,3-diol], n-butylene glycol [(butane-1,4-diol], 2,3-butylene glycol [or secbutylene glycol (butane-2,3-diol)], Triols, glycerol; Tetraols, Erythritol, Threitol, Pentols (pentanols), Xylitol, Arabitol (lyxitol), Ribitol (adonitol); Hexols, Sorbitol (Gulitol), Dulcitol (Galactitol), Mannitol, Fucitol, Iditol; Heptols, Volemitol; C12 Isomalt, C12 Maltitol, C12 Isomaltitol, C12 Lactitol (lactositol), C18 Maltotriitol, C24 Maltotetraitol; and Polyglycitol.

### Claim 6 (depends on 1)

The composition according to claim 1, characterized in that the hyaluronic acid is present in the composition in an amount comprised between 0.01% and 20% of the total weight of the composition.

### Claim 7 (depends on 1)

The composition according to claim 1, characterized in that the polyol is present in the composition in an amount between 0.05 and 90% of the total weight of the composition.

### Claim 8 (depends on 1)

The composition according to claim 1, characterized in that the carboxymethyl cellulose is present in the composition in an amount between 0.1% and 72% of the total weight of the composition.

### Claim 9 (depends on 1)

The composition according to claim 1, characterized in that the ratio between the hyaluronic acid and the polyol in the composition is between 0.0001 and 400.

### Claim 10 (depends on 1)

The composition according to claim 1, characterized in that the ratio between the hyaluronic acid and the carboxymethyl cellulose in the composition is between 0.0001 and 200.

### Claim 11 (depends on 1)

The composition according to claim 1, characterized in that the ratio in the composition between the polyol and the carboxymethyl cellulose is between 0.0007 and 900.

### Claim 12

A method comprising the use of at least one polyol and/or carboxymethyl cellulose to slow down, limit or even eliminate the degradation of hyaluronic acid, in a composition.

### Claim 13 (depends on 12)

The method according to claim 12, to slow down, limit or even eliminate the degradation of the hyaluronic acid induced by ionizing radiation.

### Claim 14 (depends on 12)

The method according to claim 12, to slow down, limit or even eliminate the degradation of the hyaluronic acid induced by oxidative stress.

### Claim 15 (depends on 1)

The composition according to claim 1, comprising hyaluronic acid and at least one polyol and carboxymethyl cellulose.

### Claim 16 (depends on 2)

The composition according to claim 2, characterized in that the hyaluronic acid has a molecular weight between 5.105 and 2.106 Da.

### Claim 17 (depends on 4)

The composition according to claim 4, characterized in that the polyol is an alkyl compound having 2 or 3 carbon atoms.

### Claim 18 (depends on 6)

The composition according to claim 6, characterized in that the hyaluronic acid is present in the composition in an amount comprised between 0.05% and 1% of the total weight of the composition.

### Claim 19 (depends on 8)

The composition according to claim 8, characterized in that the carboxymethyl cellulose is present in the composition in an amount between 1 and 5% of the total weight of the composition.

### Claim 20 (depends on 10)

The composition according to claim 10, characterized in that the ratio between the hyaluronic acid and the carboxymethyl cellulose in the composition is between 0.01 and 1.
